Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment

Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment

US Patent 11299543 · Granted Apr 12, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Cytokine profiling analysis2025
T cells with reduced surface fucosylation and methods of making and using the sa2024
Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy2023
Methods of reducing immunogenicity against factor VIII in individuals undergoing2022
Bottle2022
Cytokine profiling analysis2021
Treatment of Hodgkin lymphoma using an anti-PD-1 antibody2021
Anti-clog cap and associated containers and methods2021
Writing instrument2021